The ANA/DFS70 antibody positivity was 2.3% (n = 12) among this group; SARD patients were 33.3% (three UCTD and PsO one); healthy participants were 66.7% (six HC and two FDR), and no RA patients were positive. Here, BTG3 is linked to rheumatoid arthritis.